Organisation of the care of patients with heart failure

Lancet

Volumn 352, Issue SUPPL.1, 1998, Pages 15-18

  Erhardt, Leif R ^a   Cline, Charles M J ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DRUG USE; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; MEDICAL PRACTICE; NURSING; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY;

EID: 0031691305     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(98)90312-9     Document Type: Article

References (42)

1. Reitsma JB, Mosterd A, de Craen AJM, et al. Increase in hospital admission rates for heart failure in the Netherlands, 1980-1993. Heart 1996; 76: 388-92.
2. Kannel WB, Ho K, Thom T. Changing epidemiological features of cardiac failure. Br Heart J 1994; 72 (suppl): S3-9.
3. Ghali JK, Cooper R, Ford E. Trends in hospitalization rates for heart failure in the United States, 1973-1986. Arch Intern Med 1990; 150: 769-73.
4. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 1997; 45: 968-74.
5. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980-1990. Eur Heart J 1993; 14: 1158-62.
6. McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-33.
7. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35.
8. Studies of Left Ventricular Dysfunction (SOLVD) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
9. McMurray J, Davie A. The pharmacoecnomics of ACE inhibitors in heart failure. Pharmacoecon 1996; 9: 186-97.
10. Remes J, Miettinen H, Reuanen A, Pyorälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
11. Svensk Läkemedelzstatistik (Medical Index Sweden - MIS), 1988-1997. Stockholm: Apoteksbolaget AB, (National Corporation of Swedish Pharmacies), Sweden.
12. Cline C, Broms K, Willenheimer R, Israelsson B, Erhardt L. Hospitalization and health care costs due to congestive heart failure in the elderly. Am J Ger Cardiol 1996; 5: 10-23.
13. Opasich C, Febo O, Riccardi G, et al. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996; 78: 354-57.
14. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Arch Intern Med 1988; 148: 2013-16.
15. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990; 38: 1290-95.
16. Garg R, Yusuf S. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995; 273: 1450-56.
17. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997; 18: 736-53.
18. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on evaluation and management of heart failure). Guidelines for the evaluation and management of heart failure. Circulation 1995; 92: 2764-84.
19. Information från Läkemedelsverket. Behandling av akut och kronisk hjèrsvikt. Rekommendationer (Treatment of acute and chronic heart failure. Recommendations), no. 4, Uppsala: Läkemedelsverket, Sweden, 1992.
20. Krumholz HM, Wang Y, Parent EM, Mockalis J, Petrillo M, Radford HJ. Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997; 157: 2242-47.
21. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting. Clin Cardiol 1998; 21: 103-08.
22. Smith LE, Fabbri SA, Pai R, Ferry D, Heywood JT. Symptomatic improvement and reduced hospitalisation for patients attending a cardiomyopathy clinic. Clin Cardiol 1997; 20: 949-54.
23. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol 1997; 30: 518-26.
24. Packer M, Colucci WS, Sackner-Berstein JD, et al. Double-blind, placebo-controlled study of the effects of carvedilol in patinets with moderate to severe heart failure: the PRECISE trial. Circulation 1996; 94: 2793-99.
25. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997; 87: 643-48.
26. Wright EC. Non-compliance - or how many aunts has Matilda? Lancet 1993; 342: 909-13.
27. Gallagher EJ, Viscoli CM, Horowitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270: 742-44.
28. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of intervention to assist patients to follow prescriptions for medications. Lancet 1996; 348: 383-86.
29. Krumholz HM, Butler J, Miller J, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998; 97: 958-64.
30. Paul S. Implementing an outpatient congestive heart failure clinic: the nurse practitoner role. Heart Lung 1997; 26: 486-91.
31. Von Korff M, Gruman J, Schaefer J, Curry SJ, Wagner EH. Collaborative management in chronic illness. Ann Intern Med 1997; 127: 1097-02.
32. Rich MW, Beckham V, Wittenberg C, Level CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995; 333: 1190-95.
33. Cline CMJ, Israelsson BA, Willenheimer RB, Broms K, Erhardt LR. A structured care programme reduces hospitalisation in elderly patients with congestive heart failure. Heart Failure Society of America First Annual Scientific Meeting, Baltimore, 1997: 256 (abstr).
34. Cline CMJ, Israelsson BYA, Willenheimer RB, Broms K, Erhardt LR. A management programme for patients with heart failure is cost effective and reduces the need for hospitalisation. Heart (in press).
35. Abraham WT, Bristow MR. Specialized centers for heart failure management. Circulation 1997; 96: 2755-57.
36. Hanamanthu S, Butler J, Chomsky D, Davis S, Wilson JR. Effect of a heart failure program on hospitalisation frequency and exercise tolerance. Circulation 1997; 96: 2842-48.
37. Cintron G, Bigas C, Linares E, Aranda J, Hernandez E. Nurse practitioner role in a chronic congestive heart failure clinic: inhospital time, costs, and patient satisfaction. Heart Lung 1983; 12: 237-40.
38. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 1997; 79: 58-63.
39. Kostis JB, Rosen RC, Cosgrove NM, Shindler DM, Wilson AC. Nonpharmacologic therapy improves function and emotional status in congestive heart failure. Chest 1994; 106: 996-1001.
40. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? N Engl J Med 1996; 334: 1441-47.
41. Stewart S, Pearson S, Luke CG, Horowitz JD. Effects of home-based intervention on unplanned readmissions and out-of-hospital deaths. J Am Geriatr Soc 1998; 46: 174-80.
42. Tougaard L, Krone T, Sorknaes A, Ellegaard H, and the PASTMA group. Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. Lancet 1992; 339: 1517-20.